Complications of Pancreatic Neuroendocrine Tumor

Overview

Pancreatic neuroendocrine tumors (PNET) are a type of tumors that develop in the pancreas from a specific type of cell called a neuroendocrine cell. These cells produce and release hormones, such as insulin, gastrin, glucagon, vasoactive intestinal peptide, and somatostatin into the bloodstream. PNETs can be either benign (noncancerous) or malignant (cancerous).

PNETs can lead to various complications such as:

• Metastasis: Malignant PNETs have the potential to spread to other areas of the body, such as the liver, lungs or bone.
• Development of other medical conditions:
  • Insulinomas may cause hypoglycemia (low blood sugar) and are associated with multiple endocrine neoplasia (MEN1), neurofibromatosis type 1, and von-Hippel Lindau disease.
  • Gastrinoma may cause ulcers, acid reflux, and Zollinger-Ellison syndrome (as stomach disorder associated with too much stomach acid)
  • Glucagonomas may cause MEN1.
  • VIPomas may cause severe diarrhea.
  • Somatostatinomas may increase the risk of diabetes or gallstones.

To summarize, common complications of PNET include metastasis, symptoms from overproduced hormones, and development of other medication conditions related to the type of hormone released. Treatment options for functional tumors include medications to manage hormone-related symptoms. Surgery is often used for malignant tumors, aiming to remove as much of the tumor as possible. As always, it's important to consult with your doctor for personalized advice and guidance regarding your specific situation.